Geron Corp. (GERN)
Geron Market Cap : 719.57M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 719.57M |
| October 22, 2026 | 725.99M |
| October 21, 2026 | 745.27M |
| October 20, 2026 | 796.66M |
| October 19, 2026 | 770.96M |
| October 16, 2026 | 751.69M |
| October 15, 2026 | 790.24M |
| October 14, 2026 | 764.54M |
| October 13, 2026 | 770.96M |
| October 12, 2026 | 783.81M |
| October 09, 2026 | 787.03M |
| October 08, 2026 | 783.81M |
| October 07, 2026 | 770.96M |
| October 06, 2026 | 777.39M |
| October 05, 2026 | 777.39M |
| October 02, 2026 | 770.96M |
| October 01, 2026 | 777.39M |
| September 30, 2026 | 790.24M |
| September 29, 2026 | 796.66M |
| September 28, 2026 | 803.09M |
| September 25, 2026 | 809.51M |
| September 24, 2026 | 809.51M |
| September 23, 2026 | 796.66M |
| September 22, 2026 | 841.64M |
| September 21, 2026 | 835.21M |
| Date | Value |
|---|---|
| September 18, 2026 | 835.21M |
| September 17, 2026 | 848.06M |
| September 16, 2026 | 828.79M |
| September 15, 2026 | 841.64M |
| September 14, 2026 | 880.18M |
| September 11, 2026 | 867.33M |
| September 10, 2026 | 880.18M |
| September 09, 2026 | 899.46M |
| September 08, 2026 | 970.13M |
| September 04, 2026 | 1.009B |
| September 03, 2026 | 970.13M |
| September 02, 2026 | 1.022B |
| September 01, 2026 | 950.86M |
| August 31, 2026 | 957.28M |
| August 28, 2026 | 970.13M |
| August 27, 2026 | 982.98M |
| August 26, 2026 | 982.98M |
| August 25, 2026 | 995.83M |
| August 24, 2026 | 976.55M |
| August 21, 2026 | 976.55M |
| August 20, 2026 | 995.83M |
| August 19, 2026 | 1.022B |
| August 18, 2026 | 982.98M |
| August 17, 2026 | 982.98M |
| August 14, 2026 | 944.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Precigen, Inc. | 2.216B |
| Editas Medicine, Inc. | 368.47M |
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
Market Cap Related Metrics
| PS Ratio | 3.661 |
| Price to Book Value | 3.292 |
| Price | 1.12 |
| Earnings Yield | -9.34% |